1402582-07-3

Upstream product

• 1254713-76-2 hydrazonoyl chloride 
• 116853-75-9 C₈H₆ClF₃N₂ 
• 1254713-77-3 1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carbonitrile 
• 1402581-32-1 1-[[2-(3-chlorophenyl)-5-(trifluoromethyl)-2H-pyrazol-3-yl]-methyl]-3-[3-fluoro-4-(hydroxymethyl)-phenyl]-urea 
• 1254713-79-5 (1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methanamine 
• 1402585-33-4 phenyl (3-fluoro-4-(hydroxymethyl)phenyl)carbamate 
• 840501-15-7 (4-amino-2-fluorophenyl)methanol 
• 660432-43-9 (2-fluoro-4-nitrophenyl)methanol 
• 392-09-6 2-fluoro-4-nitro-benzoic acid methyl ester 
• 403-24-7 2-fluoro-4-nitrobenzoic acid 

Relevant academic research and scientific papers

SUBSTITUTED PYRAZOLYL-BASED CARBOXAMIDE AND UREA DERIVATIVES BEARING A PHENYL MOIETY SUBSTITUTED WITH A CO-CONTAINING GROUP AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a CO-containing group as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.